After all the arguing over drug prices, the cost of healthcare and many of the related disputes, most Americans take comfort from the fact that the nation as a whole is getting healthier and living longer. But—at this time—that is […]
Read MoreA good way to get vendors involved in pharma cold-chain services and equipment looking sideways is to ask them to provide the data they collect during shipments and deliveries. In the frictionless, IoT (Internet of Things) world we are entering, […]
Read MoreCountless Hollywood movies present the film’s heroes trapped in some dire circumstance, with hope fading, only to be saved by the arrival of reinforcements/allies/best buddies at the very end. Something of the same scenario is playing out with blockchain as […]
Read MoreFor the first time ever, adults with primary progressive multiple sclerosis, an aggressive form of multiple sclerosis, have a treatment. The intravenous drug, Ocrevus (ocrelizumab), approved by FDA last March, is the first treatment to slow the progression of PPMS […]
Read MoreFor many years, pharma companies shipping temperature-sensitive products have relied on temperature loggers to monitor the condition of the drugs while in transit. These devices have become cheap, reliable and ubiquitous. But if your organization relies solely on these devices […]
Read MoreEver since Scott Gottlieb took over as commissioner at FDA, he has sounded a constant theme of accelerating the approval of generic drugs as a way for FDA to rein in rising drug costs. In mid-October, FDA issued more than […]
Read MoreThe pharma industry is well along in a shift from traditional mass-market drugs to specialties, which now represent 43% of net drug spending (invoice price less discounts), and which has doubled its proportion in overall drug spending over the past […]
Read MoreAn environment of unprecedented information technology and digital channel innovation is rapidly changing the nature of business. Advances in information technology, including systems (customer relationship management, digital asset management), tools (data management, analytics), infrastructure (mobile, cloud) and information (big data), […]
Read MoreThe recent market news surrounding the difference between gross and net pricing for branded products brought to light the inefficiencies in today’s product distribution and management models. It is becoming increasingly evident that the industry is due and preparing for […]
Read MoreWe’ve been covering the topic of pharmaceutical traceability and compliance with the Drug Supply Chain Security Act (DSCSA) closely for years, in part because its implications are so fundamental to how drugs will be distributed and dispensed nationally and globally […]
Read More